Loncastuximab Tesirine
ADCT-402-311
Phase 3 small_molecule active
Quick answer
Loncastuximab Tesirine for Relapsed Diffuse Large B-Cell Lymphoma is a Phase 3 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- Relapsed Diffuse Large B-Cell Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active